Lipoprotein disorder Clinical Trials
Conditions / Lipoprotein disorder
Delta Trials records 8 clinical trials for Lipoprotein disorder in its publicly accessible dataset. From the full dataset, 3 actively seeking eligible participants and 2 trials have reached completion. This research is conducted across 172 study locations around the world. An additional 3 trials are active but not currently open for enrollment. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
8
Total Trials
3
Recruiting
2
Completed
3
Other Active
0
Terminated since 2020
172
Study Locations
Browse by location (172 total)
- Nanchang, China 3 trialsAll trials in Nanchang, China
- Sanya, China 3 trialsAll trials in Sanya, China
- Xi’an, China 3 trialsAll trials in Xi’an, China
- Frankfurt am Main, Germany 3 trialsAll trials in Frankfurt am Main, Germany
- Lima, United States 2 trialsAll trials in Lima, United States
- Beijing, China 2 trialsAll trials in Beijing, China
- Miyazaki, Japan 2 trialsAll trials in Miyazaki, Japan
- Berlin, Germany 2 trialsAll trials in Berlin, Germany
- Magdeburg, Germany 2 trialsAll trials in Magdeburg, Germany
- Yardley, United States 2 trialsAll trials in Yardley, United States
- Dorchester, United States 2 trialsAll trials in Dorchester, United States
- Dortmund, Germany 2 trialsAll trials in Dortmund, Germany
- Baltimore, United States 2 trialsAll trials in Baltimore, United States
- Katy, United States 2 trialsAll trials in Katy, United States
- Nanjing, China 2 trialsAll trials in Nanjing, China
- Harbin, China 2 trialsAll trials in Harbin, China
- Luoyang, China 2 trialsAll trials in Luoyang, China
- Timişoara, Romania 1 trialAll trials in Timişoara, Romania
- Târgu Mureş, Romania 1 trialAll trials in Târgu Mureş, Romania
- Tupelo, United States 1 trialAll trials in Tupelo, United States